Related Experiment Videos
Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model
J C Cohen1, S L Morrow, R J Cork
1Department of Medicine, Louisiana State University, School of Medicine, New Orleans, Louisiana 70112, USA.
Abstract:
Cystic fibrosis transmembrane conductance regulator (cftr) gene mutations are thought to result in cystic fibrosis due to an absence of the protein's chloride channel. Recently, the lethal intestinal blockage in the cftr knockout mouse was reversed by a single in utero dose of a recombinant adenovirus containing the human cftr gene. The rescue of these animals did not require continuous expression of the gene and the cAMP-dependent chloride channel was not permanently restored. These data suggested that cftr was required for normal development of the intestine but not for normal function of the adult organ. Phenotypic changes in the intestines and lungs of in utero cftr-treated knockout and heterozygous mice revealed that altered development was induced. The intestines of the untreated knockout mice were shown to be deficient in both intracellular calcium and UTP receptors. Both of these deficiencies were partially corrected in the rescued knockout mice, whereas treatment of heterozygous animals disrupted the normal pattern of these markers. Examination of the lungs of knockout cftr (-/-) mice with lectins showed an increase in secreted glycoconjugates containing alpha(2,6)-sialic acid and fucose as compared with control heterozygotes. The in utero-treated knockouts showed an increase in this material as well, but it was contained in intracellular vesicles. Electron microscopy of these tissues confirmed the developmental alteration of secretory cell differentiation in the lungs. These data show that cftr is required in both the lung and intestines for normal differentiation of a secretory cell population and that in its absence these cells fail to develop properly.
Insights
Cystic fibrosis transmembrane conductance regulator (CFTR) is crucial for normal intestinal and lung development. In utero gene therapy in CFTR knockout mice partially corrected developmental defects, highlighting CFTR's role in secretory cell differentiation.
Area of Science:
- Developmental Biology
- Genetics
- Molecular Biology
Background:
- Cystic fibrosis transmembrane conductance regulator (CFTR) mutations cause cystic fibrosis by disrupting chloride channel function.
- CFTR absence leads to lethal intestinal blockage in knockout mice.
- Previous studies suggested CFTR's role in adult organ function.
Purpose of the Study:
- To investigate the role of CFTR in the normal development of the intestine and lungs.
- To determine if in utero gene therapy could rescue developmental defects in CFTR knockout mice.
- To analyze the impact of CFTR on secretory cell differentiation.
Main Methods:
- In utero administration of a recombinant adenovirus containing the human CFTR gene to knockout mice.
- Analysis of intestinal and lung tissues using lectin staining and electron microscopy.
- Assessment of intracellular calcium and UTP receptors in intestinal cells.
Main Results:
- In utero CFTR gene therapy partially reversed lethal intestinal blockage in knockout mice.
- CFTR deficiency impaired intestinal development, affecting calcium and UTP receptor levels.
- Lung tissues in knockout mice showed altered secretory cell differentiation with increased alpha(2,6)-sialic acid and fucose.
- In utero treatment partially corrected lung secretory cell differentiation but altered it in heterozygotes.
Conclusions:
- CFTR is essential for the normal differentiation of secretory cell populations in both the lungs and intestines.
- CFTR deficiency leads to improper development of these secretory cells.
- In utero gene therapy can partially rescue developmental defects but may also induce alterations in heterozygous models.